Jazz Pharmaceuticals PLC (JAZZ)
110.07
+0.78
(+0.71%)
USD |
NASDAQ |
May 03, 16:00
110.07
0.00 (0.00%)
After-Hours: 18:15
Jazz Pharmaceuticals Price to Book Value: 1.877 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.864 |
| May 01, 2024 | 1.881 |
| April 30, 2024 | 1.889 |
| April 29, 2024 | 1.897 |
| April 26, 2024 | 1.867 |
| April 25, 2024 | 1.832 |
| April 24, 2024 | 1.847 |
| April 23, 2024 | 1.870 |
| April 22, 2024 | 1.856 |
| April 19, 2024 | 1.875 |
| April 18, 2024 | 1.864 |
| April 17, 2024 | 1.826 |
| April 16, 2024 | 1.857 |
| April 15, 2024 | 1.892 |
| April 12, 2024 | 1.886 |
| April 11, 2024 | 1.935 |
| April 10, 2024 | 1.945 |
| April 09, 2024 | 1.944 |
| April 08, 2024 | 1.962 |
| April 05, 2024 | 1.985 |
| April 04, 2024 | 1.964 |
| April 03, 2024 | 1.994 |
| April 02, 2024 | 2.004 |
| April 01, 2024 | 2.029 |
| March 31, 2024 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.009 |
| March 27, 2024 | 2.010 |
| March 26, 2024 | 1.968 |
| March 25, 2024 | 2.015 |
| March 22, 2024 | 2.032 |
| March 21, 2024 | 2.070 |
| March 20, 2024 | 2.082 |
| March 19, 2024 | 2.085 |
| March 18, 2024 | 2.059 |
| March 15, 2024 | 2.017 |
| March 14, 2024 | 1.974 |
| March 13, 2024 | 1.965 |
| March 12, 2024 | 1.932 |
| March 11, 2024 | 1.946 |
| March 08, 2024 | 1.961 |
| March 07, 2024 | 1.941 |
| March 06, 2024 | 1.955 |
| March 05, 2024 | 1.976 |
| March 04, 2024 | 1.961 |
| March 01, 2024 | 1.983 |
| February 29, 2024 | 1.984 |
| February 28, 2024 | 2.164 |
| February 27, 2024 | 2.206 |
| February 26, 2024 | 2.215 |
| February 23, 2024 | 2.207 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.583
Minimum
Mar 23 2020
3.666
Maximum
Dec 22 2022
2.487
Average
2.466
Median
Price to Book Value Benchmarks
| Alkermes PLC | 3.342 |
| Endo International PLC | -- |
| Medtronic PLC | 2.094 |
| Perrigo Co PLC | 0.9320 |
| Iterum Therapeutics PLC | -- |
Price to Book Value Related Metrics
| PE Ratio | 22.69 |
| PS Ratio | 1.983 |
| Price to Free Cash Flow | 7.751 |
| Price | 110.07 |
| Earnings Yield | 4.41% |
| Market Cap | 6.939B |
| Operating PE Ratio | 13.94 |
| Normalized PE Ratio | 21.58 |